Zoledronic acid is effective for reducing hip fracture risk among postmenopausal women with osteoporosis. Zoledronic acid is effective for reducing hip fracture risk among postmenopausal women with ...

June 4, 2009 — The FDA this month has approved zoledronic acid infusion (Reclast, Novartis Pharmaceuticals Corp) for the prevention of postmenopausal osteoporosis during a 2-year period. "It is very ...

Please provide your email address to receive an email when new articles are posted on . A single injection of zoledronic acid was an effective prevention strategy for osteoporosis in postmenopausal ...

Use of zoledronic acid for the treatment of osteoporosis enhanced bone mineral density and reduced bone turnover in patients, according to results. Overall, 154 adult patients (149 women) with ...

(HealthDay News) – For men with osteoporosis, a once-yearly infusion with zoledronic acid is associated with fewer vertebral fractures and improved bone health compared with placebo, according to a ...

Zoledronic acid and denosumab demonstrated comparable fracture and mortality outcomes among patients with type 2 diabetes and osteoporosis. Zoledronic acid and denosumab demonstrate comparable ...

A single intravenous dose of the osteoporosis drug zoledronic acid improved bone mineral density in a group of frail elderly women living in nursing homes and long-term-care facilities. A single ...

RTOG 0518 evaluated the potential benefit of zoledronic acid therapy in preventing bone fractures for patients with high grade and/or locally advanced, non-metastatic prostate adenocarcinoma receiving ...

Older women with osteoporosis who received yearly infusions of a drug that prevents bone loss had far fewer fractures than did peers who didn’t get the drug. Over 3 years, the women who received ...

The report by Michaelson et al is a well-conducted, randomized trial comparing a single annual dose of zoledronic acid with placebo in men with prostate cancer who did not have bone metastases or ...

...74.2% of participants ... [preferred an] annual intravenous infusion of ZOL ... in comparison to ... weekly oral alendronate Adherence to treatment is a considerable concern in all areas of ...

Men with osteoporosis who received zoledronic acid experienced a 67% risk reduction for new vertebral fractures (relative risk, 0.33; 95% confidence interval, 0.16 - 0.70; P = .002) compared with men ...